Synchronous deletion of Mtv-superantigen-reactive thymocytes in the CD3medium/high CD4+ CD8+ subset

Scandinavian Journal of Immunology

Volumn 52, Issue 6, 2000, Pages 550-554

  Sheard, M A ^a   Sharrow, S O ^b   Takahama, Y ^c  

^a MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL MATURATION; FLOW CYTOMETRY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; THYMOCYTE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD8; CHIMERA; CLONAL DELETION; FEMALE; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SUPERANTIGENS; T-LYMPHOCYTE SUBSETS; THYMUS GLAND; VIRAL ENVELOPE PROTEINS;

EID: 0034533732     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00814.x     Document Type: Article

References (32)

1. T cell selection in the thymus
2. Negative selection by endogenous antigen and superantigen occurs at multiple thymic sites
3. Characterization of the Mlsf system. II. Identification of mouse mammary tumor virus proviruses involved in the clonal deletion of self-Mlsf-reactive T cells
4. The J alpha segment contributes to the affinity of V beta 6+ cells for vSAG-7 (Mls-la) presented by I-A molecules
5. Superantigens: Bacterial and viral proteins that manipulate the immune system
6. Mouse mammary tumor virus: Immunological interplays between virus and host
7. A virus-encoded 'superantigen' in a retrovirus-induced immunodeficiency syndrome of mice
8. Current Protocols in Immunology
9. The MHC molecule I-E is necessary but not sufficient for the clonal deletion of V beta 11-bearing T cells
10. Capacity of unprimed CD4+ and CD8+ T cells expressing V beta 11 receptors to respond to I-E alloantigens in vivo
11. Molecular basis for the nonexpression of V beta 17 in some strains of mice
12. Factors influencing the fate of T cells responding to Mls antigens
13. Expression of two structurally identical viral superantigens results in thymic elimination at distinct developmental stages
14. Superantigens of mouse mammary tumor viruses
15. Timing of deletion of autoreactive V beta 6+ cells and down-modulation of either CD4 or CD8 on phenotypically distinct CD4+8+ subsets of thymocytes expressing intermediate or high levels of T cell receptor
16. Heterogeneous expression of recombination activating genes and surface CD5 in CD31ow CD4+CD8+ thymocytes
17. Negative selection of precursor thymocytes before their differentiation into CD4+CD8+ cells
18. Distinct sequence of negative or positive selection implied by thymocyte T-cell receptor densities
19. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes
20. Positive and negative selection of an antigen receptor on T cells in transgenic mice
21. Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene
22. Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice
23. bcl-2 proto-oncogene expression during human T cell development. Evidence for biphasic regulation
24. Expression of the BcI-2 protein in murine and human thymocytes and in peripheral T lymphocytes
25. Developmental regulation of bcl-2 expression in the thymus
26. Evidence for a differential avidity model of T cell selection in the thymus
27. Lck-independent triggering of T-cell antigen receptor signal transduction by staphylococcal enterotoxins
28. Differences in the avidity of TCR interactions with a superantigenic ligand affect negative selection but do not allow positive selection
29. Physiologic expression of two superantigens in the BDF1 mouse
30. T cell activation is not a prerequisite for peripheral tolerance induction to Mls la
31. Two subsets of epithelial cells in the thymic medulla
32. Intra- and extrathymic B cells in physiologic and pathologic conditions. Immunohistochemical study on normal thymus mid lymphofollicular hyperplasia of the thymus